Loading...

Zoetis MFA Portfolio Integration Will Expand Domestic And International Demand

Published
17 Sep 24
Updated
27 Aug 25
AnalystConsensusTarget's Fair Value
US$26.00
47.9% overvalued intrinsic discount
27 Aug
US$38.46
Loading
1Y
79.1%
7D
21.9%

Author's Valuation

US$26.0

47.9% overvalued intrinsic discount

AnalystConsensusTarget Fair Value

Shared on01 May 25
Fair value Increased 36%

Shared on23 Apr 25
Fair value Decreased 5.26%

AnalystConsensusTarget has decreased future PE multiple from 6.3x to 5.4x.

Shared on17 Apr 25
Fair value Decreased 8.41%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on09 Apr 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on02 Apr 25
Fair value Increased 6.03%

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on26 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on19 Mar 25

AnalystConsensusTarget made no meaningful changes to valuation assumptions.

Shared on11 Mar 25
Fair value Decreased 20%

AnalystConsensusTarget has decreased revenue growth from 16.1% to 12.4% and increased profit margin from 7.9% to 9.4%.